Skip to content

Advertisement

BMC Musculoskeletal Disorders

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Antiresorptive effect of a cathepsin K inhibitor ONO-5334 and its relationship to BMD increase in a phase II trial for postmenopausal osteoporosis

  • Makoto Tanaka1Email author,
  • Yoshitaka Hashimoto2,
  • Chihiro Hasegawa2,
  • Steve Deacon3 and
  • Richard Eastell4
BMC Musculoskeletal DisordersBMC series – open, inclusive and trusted201718:267

https://doi.org/10.1186/s12891-017-1625-y

Received: 6 February 2017

Accepted: 12 June 2017

Published: 19 June 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
6 Feb 2017 Submitted Original manuscript
12 Mar 2017 Reviewed Reviewer Report - Christina Abdel Shaheed
14 Mar 2017 Reviewed Reviewer Report - David Goltzman
28 Mar 2017 Author responded Author comments - Makoto Tanaka
Resubmission - Version 2
28 Mar 2017 Submitted Manuscript version 2
4 Apr 2017 Reviewed Reviewer Report - David Goltzman
14 Apr 2017 Reviewed Reviewer Report - Wei Yang
27 Apr 2017 Author responded Author comments - Makoto Tanaka
Resubmission - Version 3
27 Apr 2017 Submitted Manuscript version 3
30 May 2017 Author responded Author comments - Makoto Tanaka
Resubmission - Version 4
30 May 2017 Submitted Manuscript version 4
Publishing
12 Jun 2017 Editorially accepted
19 Jun 2017 Article published 10.1186/s12891-017-1625-y

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Research Promotion, Ono Pharmaceutical Co., Ltd
(2)
Translational Medicine Center, Ono Pharmaceutical Co., Ltd
(3)
Clinical Development, Ono Pharma UK Ltd
(4)
Academic Unit of Bone Metabolism, University of Sheffield

Advertisement